153 related articles for article (PubMed ID: 37993776)
1. Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial.
Agarwal N; Shah KK; Dansie K; Bennett PN; Greenham L; Brown C; Smyth B; McDonald S; Jesudason S; Viecelli AK; Morton RL;
BMC Nephrol; 2023 Nov; 24(1):345. PubMed ID: 37993776
[TBL] [Abstract][Full Text] [Related]
2. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.
Greenham L; Bennett PN; Dansie K; Viecelli AK; Jesudason S; Mister R; Smyth B; Westall P; Herzog S; Brown C; Handke W; Palmer SC; Caskey FJ; Couchoud C; Simes J; McDonald SP; Morton RL
Trials; 2022 May; 23(1):419. PubMed ID: 35590395
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring WIth Feedback Trial (SWIFT) pilot: protocol for a qualitative study in Australia.
Duncanson E; Bennett PN; Viecelli A; Dansie K; Handke W; Tong A; Palmer S; Jesudason S; McDonald SP; Morton RL;
BMJ Open; 2020 Nov; 10(11):e039014. PubMed ID: 33158824
[TBL] [Abstract][Full Text] [Related]
4. Perspectives of Patients, Nurses, and Nephrologists About Electronic Symptom Monitoring With Feedback in Hemodialysis Care.
Viecelli AK; Duncanson E; Bennett PN; D'Antoine M; Dansie K; Handke W; Tong A; Palmer S; Jesudason S; McDonald S; Morton RL;
Am J Kidney Dis; 2022 Aug; 80(2):215-226.e1. PubMed ID: 35085687
[TBL] [Abstract][Full Text] [Related]
5. Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: A cross-sectional survey study.
Morton RL; Lioufas N; Dansie K; Palmer SC; Jose MD; Raj R; Salmon A; Sypek M; Tong A; Ludlow M; Boudville N; McDonald S
Nephrology (Carlton); 2020 Jan; 25(1):14-21. PubMed ID: 30838732
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis.
Murea M; Highland BR; Yang W; Dressler E; Russell GB
BMC Nephrol; 2022 Sep; 23(1):322. PubMed ID: 36167537
[TBL] [Abstract][Full Text] [Related]
8. Enhanced psychological care in cardiac rehabilitation services for patients with new-onset depression: the CADENCE feasibility study and pilot RCT.
Richards SH; Campbell JL; Dickens C; Anderson R; Gandhi M; Gibson A; Kessler D; Knight L; Kuyken W; Richards DA; Taylor RS; Turner K; Ukoumunne OC; Davey A; Warren FC; Winder RE; Wright CA
Health Technol Assess; 2018 May; 22(30):1-220. PubMed ID: 29856312
[TBL] [Abstract][Full Text] [Related]
9. "You need a team": perspectives on interdisciplinary symptom management using patient-reported outcome measures in hemodialysis care-a qualitative study.
Baragar B; Schick-Makaroff K; Manns B; Love S; Donald M; Santana M; Corradetti B; Finlay J; Johnson JA; Walsh M; Elliott MJ
J Patient Rep Outcomes; 2023 Jan; 7(1):3. PubMed ID: 36662325
[TBL] [Abstract][Full Text] [Related]
10. Self-reported MeasUrement of Physical and PsychosOcial Symptoms Response Tool (SUPPORT-dialysis): systematic symptom assessment and management in patients on in-centre haemodialysis - a parallel arm, non-randomised feasibility pilot study protocol.
Gill JK; Pucci M; Samudio A; Ahmed T; Siddiqui R; Edwards N; Marticorena RM; Donnelly S; Lok C; Wentlandt K; Wolofsky K; Mucsi I
BMJ Open; 2024 Jan; 14(1):e080712. PubMed ID: 38296283
[TBL] [Abstract][Full Text] [Related]
11. Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults.
Kendrick T; El-Gohary M; Stuart B; Gilbody S; Churchill R; Aiken L; Bhattacharya A; Gimson A; Brütt AL; de Jong K; Moore M
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011119. PubMed ID: 27409972
[TBL] [Abstract][Full Text] [Related]
12. Sexual health promotion in people with severe mental illness: the RESPECT feasibility RCT.
Hughes E; Mitchell N; Gascoyne S; Moe-Byrne T; Edmondson A; Coleman E; Millett L; Ali S; Dare C; Hewitt C; Johnson S; Llewellyn C; Mercer C; Nolan F; Walker C; Watson J
Health Technol Assess; 2019 Dec; 23(65):1-136. PubMed ID: 31854292
[TBL] [Abstract][Full Text] [Related]
13. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.
Kyte D; Bishop J; Brettell E; Calvert M; Cockwell P; Dutton M; Eddington H; Hadley G; Ives NJ; Jackson LJ; Stringer S; Valente M
BMJ Open; 2018 Oct; 8(10):e026080. PubMed ID: 30373785
[TBL] [Abstract][Full Text] [Related]
14. Stratified primary care versus non-stratified care for musculoskeletal pain: findings from the STarT MSK feasibility and pilot cluster randomized controlled trial.
Hill JC; Garvin S; Chen Y; Cooper V; Wathall S; Saunders B; Lewis M; Protheroe J; Chudyk A; Dunn KM; Hay E; van der Windt D; Mallen C; Foster NE
BMC Fam Pract; 2020 Feb; 21(1):30. PubMed ID: 32046647
[TBL] [Abstract][Full Text] [Related]
15. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
[TBL] [Abstract][Full Text] [Related]
16. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC
JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856
[TBL] [Abstract][Full Text] [Related]
17. Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease.
Kyte D; Anderson N; Bishop J; Bissell A; Brettell E; Calvert M; Chadburn M; Cockwell P; Dutton M; Eddington H; Forster E; Hadley G; Ives NJ; Jackson LJ; O'Brien S; Price G; Sharpe K; Stringer S; Verdi R; Waters J; Wilcockson A
BMJ Open; 2022 Mar; 12(3):e050610. PubMed ID: 35304391
[TBL] [Abstract][Full Text] [Related]
18. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
19. A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT.
Gunn H; Andrade J; Paul L; Miller L; Creanor S; Stevens K; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman J
Health Technol Assess; 2019 Jun; 23(27):1-166. PubMed ID: 31217069
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
